BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21470416)

  • 1. Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland.
    Nyante SJ; Faupel-Badger JM; Sherman ME; Pfeiffer RM; Gaudet MM; Falk RT; Andaya AA; Lissowska J; Brinton LA; Peplonska B; Vonderhaar BK; Chanock S; Garcia-Closas M; Figueroa JD
    Breast Cancer Res; 2011 Apr; 13(2):R42. PubMed ID: 21470416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
    Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
    BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of gene polymorphisms in prolactin and its receptor with breast cancer risk in Taiwanese women.
    Mong FY; Kuo YL; Liu CW; Liu WS; Chang LC
    Mol Biol Rep; 2011 Oct; 38(7):4629-36. PubMed ID: 21125332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of prolactin and its receptor gene regions with familial breast cancer.
    Vaclavicek A; Hemminki K; Bartram CR; Wagner K; Wappenschmidt B; Meindl A; Schmutzler RK; Klaes R; Untch M; Burwinkel B; Försti A
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1513-9. PubMed ID: 16434456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland.
    Faupel-Badger JM; Sherman ME; Garcia-Closas M; Gaudet MM; Falk RT; Andaya A; Pfeiffer RM; Yang XR; Lissowska J; Brinton LA; Peplonska B; Vonderhaar BK; Figueroa JD
    Br J Cancer; 2010 Sep; 103(7):1097-102. PubMed ID: 20736944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Determinants of Nipple Aspiration Fluid Yield.
    Shidfar A; Wang J; Wiesenfeld E; Zhang W; Scholtens D; Fought A; Chatterton RT; Khan SA
    Ann Surg Oncol; 2016 Aug; 23(8):2487-93. PubMed ID: 27027309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin improves hepatic steatosis via CD36 pathway.
    Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
    J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of
    Sa-Nguanraksa D; Thasripoo C; Samarnthai N; Kummalue T; Thumrongtaradol T; O-Charoenrat P
    Transl Cancer Res; 2020 Oct; 9(10):6344-6353. PubMed ID: 35117242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin levels and breast cancer risk by tumor expression of prolactin-related markers.
    Hathaway CA; Rice MS; Collins LC; Chen D; Frank DA; Walker S; Clevenger CV; Tamimi RM; Tworoger SS; Hankinson SE
    Breast Cancer Res; 2023 Mar; 25(1):24. PubMed ID: 36882838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of polymorphisms for prolactin and prolactin receptor genes with broody traits in chickens.
    Jiang RS; Xu GY; Zhang XQ; Yang N
    Poult Sci; 2005 Jun; 84(6):839-45. PubMed ID: 15971519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus.
    Mellai M; Giordano M; D'Alfonso S; Marchini M; Scorza R; Danieli M.G.; Leone M; Ferro I; Liguori M; Trojano M; Ballerini C; Massacesi L; Cannoni S; Bomprezzi R; Momigliano-Richiardi P
    Hum Immunol; 2003 Feb; 64(2):274-84. PubMed ID: 12559630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
    J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors.
    Bogorad RL; Courtillot C; Mestayer C; Bernichtein S; Harutyunyan L; Jomain JB; Bachelot A; Kuttenn F; Kelly PA; Goffin V; Touraine P;
    Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14533-8. PubMed ID: 18779591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women.
    Eliassen AH; Tworoger SS; Hankinson SE
    Int J Cancer; 2007 Apr; 120(7):1536-41. PubMed ID: 17211859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin as a local growth promoter in patients with breast cancer: GCRI experience.
    Bhatavdekar JM; Patel DD; Shah NG; Vora HH; Suthar TP; Ghosh N; Chikhlikar PR; Trivedi TI
    Eur J Surg Oncol; 2000 Sep; 26(6):540-7. PubMed ID: 11034803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
    Tworoger SS; Sluss P; Hankinson SE
    Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness.
    Kavarthapu R; Dufau ML
    Front Endocrinol (Lausanne); 2022; 13():949396. PubMed ID: 36187116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin as a biomarker for treatment response and tardive dyskinesia in schizophrenia subjects: old thoughts revisited from a genetic perspective.
    Souza RP; Meltzer HY; Lieberman JA; Voineskos AN; Remington G; Kennedy JL
    Hum Psychopharmacol; 2011 Jan; 26(1):21-7. PubMed ID: 21305610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro.
    Langan EA; Ramot Y; Hanning A; Poeggeler B; Bíró T; Gaspar E; Funk W; Griffiths CE; Paus R
    Br J Dermatol; 2010 May; 162(5):1127-31. PubMed ID: 20302576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.
    Lee E; Schumacher F; Lewinger JP; Neuhausen SL; Anton-Culver H; Horn-Ross PL; Henderson KD; Ziogas A; Van Den Berg D; Bernstein L; Ursin G
    Breast Cancer Res; 2011 Apr; 13(2):R37. PubMed ID: 21457551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.